111
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

BICDL1 Predicts Poor Prognosis and is Correlated with Methylation and Immune Infiltration in Colorectal Cancer

ORCID Icon, , , &
Pages 1109-1126 | Received 25 Aug 2023, Accepted 11 Dec 2023, Published online: 21 Dec 2023

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca a Cancer J Clinicians. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Cao M, Li H, Sun D, et al. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun. 2020;40(5):205–210. doi:10.1002/cac2.12025
  • Li N, Lu B, Luo C, et al. Incidence, mortality, survival, risk factor and screening of colorectal cancer: a comparison among China, Europe, and northern America. Cancer Letters. 2021;522:255–268. doi:10.1016/j.canlet.2021.09.034
  • Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325(7):669–685. doi:10.1001/jama.2021.0106
  • Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. doi:10.1016/S0140-6736(19)32319-0
  • Terenzio M, Schiavo G. The more, the better: the BICD family gets bigger. EMBO J. 2010;29(10):1625–1626. doi:10.1038/emboj.2010.78
  • Vazquez-Pianzola P, Beuchle D, Saro G, et al. Female meiosis II and pronuclear fusion require the microtubule transport factor Bicaudal D. Development. 2022;149(13). doi:10.1242/dev.199944
  • Schlager MA, Kapitein LC, Grigoriev I, et al. Pericentrosomal targeting of Rab6 secretory vesicles by Bicaudal-D-related protein 1 (BICDR-1) regulates neuritogenesis. EMBO J. 2010;29(10):1637–1651. doi:10.1038/emboj.2010.51
  • Vivian J, Rao AA, Nothaft FA, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314–316. doi:10.1038/nbt.3772
  • Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8
  • Gene Ontology Consortium. Gene ontology consortium: going forward. Nucleic Acids Res. 2015;43:D1049–1056.
  • Kanehisa M, Furumichi M, Sato Y, et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587–d592.
  • Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2(3):100141. doi:10.1016/j.xinn.2021.100141
  • Gustavsson EK, Zhang D, Reynolds RH, et al. ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinformatics. 2022;38(15):3844–3846. doi:10.1093/bioinformatics/btac409
  • Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
  • Chen B, Khodadoust MS, Liu CL, et al. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. Methods Mol Biol. 2018;1711:243–259.
  • In J, Lee DK. Survival analysis: part II - applied clinical data analysis. Korean J Anesthesiol. 2023;76(1):84–85. doi:10.4097/kja.19183.e1
  • Huang B, Feng Y, Mo SB, et al. Smaller tumor size is associated with poor survival in T4b colon cancer. World J Gastroenterol. 2016;22(29):6726–6735. doi:10.3748/wjg.v22.i29.6726
  • Atkin W, Wooldrage K, Parkin DM, et al. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial. Lancet. 2017;389(10076):1299–1311. doi:10.1016/S0140-6736(17)30396-3
  • Schlager MA, Serra-Marques A, Grigoriev I, et al. Bicaudal d family adaptor proteins control the velocity of Dynein-based movements. Cell Rep. 2014;8(5):1248–1256. doi:10.1016/j.celrep.2014.07.052
  • Huang SP, Chang YC, Low QH, et al. BICD1 expression, as a potential biomarker for prognosis and predicting response to therapy in patients with glioblastomas. Oncotarget. 2017;8(69):113766–113791. doi:10.18632/oncotarget.22667
  • Jiang Y, Yao B, Chen T, et al. BICD1 functions as a prognostic biomarker and promotes hepatocellular carcinoma progression. Pathol Res Pract. 2020;216(4):152858. doi:10.1016/j.prp.2020.152858
  • Kondratick CM, Washington MT, Spies M. Making Choices: DNA replication fork recovery mechanisms. Semin Cell Dev Biol. 2021;113:27–37. doi:10.1016/j.semcdb.2020.10.001
  • Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29(3):212–226. doi:10.1016/j.tcb.2018.12.001
  • Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36(11):1461–1473. doi:10.1038/onc.2016.304
  • Yu F, Yu C, Li F, et al. Wnt/β-catenin signaling in cancers and targeted therapies. Signal Transduct Target. 2021;6(1):307. doi:10.1038/s41392-021-00701-5
  • Koni M, Pinnarò V, Brizzi MF. The Wnt signalling pathway: a tailored target in cancer. Int J Mol Sci. 2020;21(20):7697. doi:10.3390/ijms21207697
  • Haseeb M, Pirzada RH, Ain QU, et al. Wnt signaling in the regulation of immune cell and cancer therapeutics. Cells. 2019;8(11):1380. doi:10.3390/cells8111380
  • Li X, Xiang Y, Li F, et al. WNT/β-catenin signaling pathway regulating T Cell-Inflammation in the tumor microenvironment. Front Immunol. 2019;10:2293. doi:10.3389/fimmu.2019.02293
  • Zhou Y, Xu J, Luo H, et al. Wnt signaling pathway in cancer immunotherapy. Cancer Letters. 2022;525:84–96. doi:10.1016/j.canlet.2021.10.034
  • Golub R. The Notch signaling pathway involvement in innate lymphoid cell biology. Biomedical Journal. 2021;44(2):133–143. doi:10.1016/j.bj.2020.12.004
  • Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423–1437. doi:10.1038/nm.3394
  • Zhang H, Liu Z, Wen H, et al. Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer. Cancer Immunol Immunother. 2022;71(10):2511–2522. doi:10.1007/s00262-022-03173-w
  • Tang Q, Chen Y, Li X, et al. The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers. Front Immunol. 2022;13:964442. doi:10.3389/fimmu.2022.964442
  • Yan B, Xiong J, Ye Q, et al. Correlation and prognostic implications of intratumor and tumor draining lymph node Foxp3(+) T regulatory cells in colorectal cancer. BMC gastroenterology. 2022;22(1):122. doi:10.1186/s12876-022-02205-0
  • Olguín JE, Medina-Andrade I, Rodríguez T, et al. Relevance of regulatory T cells during colorectal cancer development. Cancers. 2020;12(7):1888. doi:10.3390/cancers12071888
  • Salinas N, Olguín JE, Castellanos C, et al. T cell suppression in vitro during T oxoplasma gondii Infection is the Result of IL −2 competition between tregs and T cells leading to death of proliferating T cells. Scand J Immunol. 2014;79(1):1–11. doi:10.1111/sji.12120